Amgen Inc (BSP:AMGN34)
R$ 64.91 +0.43 (+0.67%) Market Cap: 1.00 Tn Enterprise Value: 1.24 Tn PE Ratio: 24.94 PB Ratio: 21.04 GF Score: 88/100

Amgen Inc at Goldman Sachs Healthcare Conference Transcript

Jun 09, 2026 / 01:20PM GMT
Release Date Price: R$64.13 (+0.36%)
Salveen Richter
Goldman Sachs Group Inc - Analyst

Good morning. Thank you for joining us. It's my pleasure to introduce the Amgen team. With us, we have Peter Griffith, Chief Financial Officer; Murdo Gordon, Head of Global Commercial Operations; Andrew Martin, Head of US Business Operations; and Casey Capparelli, Head of Investor Relations.

With that, I'm going to turn it over to you, Peter, for some opening remarks.

Peter Griffith
Amgen Inc - Chief Financial Officer, Executive Vice President

Great. Thank you, Salveen. Good morning, everyone. Salveen, congratulations on that Knicks win last night.

Salveen Richter
Goldman Sachs Group Inc - Analyst

Yes.

Peter Griffith
Amgen Inc - Chief Financial Officer, Executive Vice President

I understand you're now one of the top Knicks fans around.

Salveen Richter;Peter Griffith
Goldman Sachs Group Inc - Analyst;Amgen Inc - Chief

Yes.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot